We thought we had it all figured out. After curative resection of colon and rectal cancer, all clinicians know what to do. The National Comprehensive Cancer Network guidelines1 have been very clear and specific. For stage I, clinicians followup with colonoscopy, and for stages II and III, a combination of physical examination, carcinoembryonic antigen, colonoscopy, and computed tomographic scan of the chest abdomen and pelvis at very specific intervals for a total of 5 years. What can go wrong with such a detailed plan?
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Fichera A. Less Is More in Colorectal Cancer Posttreatment Surveillance. JAMA Surg. 2018;153(10):877. doi:https://doi.org/10.1001/jamasurg.2018.2066
Browse and subscribe to JAMA Network podcasts!
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: